The use of short-acting nifedipine in children with hypertension: Another example of the need for comprehensive drug testing in children

Journal of Pediatrics

Volumn 139, Issue 1, 2001, Pages 7-9

  Sinaiko, Alan R ^a,b   Daniels, Stephen R ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NICARDIPINE; NIFEDIPINE;

ANTIHYPERTENSIVE THERAPY; BODY WEIGHT; CARDIOTOXICITY; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; DRUG EFFICACY; DRUG FORMULATION; DRUG SCREENING; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERTENSION; NEUROTOXICITY; PRIORITY JOURNAL;

EID: 0034973469     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.116163     Document Type: Article

References (11)

1. Adverse drug reactions in neonates
2. Calcium channel blockers: Pharmacology and place in therapy of pediatric hypertension
3. A moratorium should be placed on the use of short-acting nifedipine for hypertensive crises
4. The use of short-acting nifedipine in pediatric patients with hypertension
5. Nifedipine poisoning in a child
6. Renal failure as a complication of acute antihypertensive therapy
7. Management of hypertensive emergencies
8. Treatment of neonatal hypertension with captopril
9. Intravenous nicardipine for treatment of severe hypertension in children
10. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorothalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
11. Effects of calcium antagonists on the risks of coronary heart disease, cancer, and bleeding